MCDERMOTT WILL & SCHULTE LLP for SURESCRIPTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Efforts to advance interoperability and to ensure that technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services sector in a timely way, including efforts to advance Cures 2.0 (H.R. 6000), which would improve the process for updating the SCRIPT electronic prescribing standard to allow for more expeditious adoption of updated electronic prescribing standards.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KAREN SEALANDER | — |
| SCOTT AARON WEINSTEIN | — |
Science/Technology SCI
Efforts to advance interoperability and to ensure that technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services sector in a timely way, including efforts to advance Cures 2.0 (H.R. 6000), which would improve the process for updating the SCRIPT electronic prescribing standard to allow for more expeditious adoption of updated electronic prescribing standards.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KAREN SEALANDER | — |
| SCOTT AARON WEINSTEIN | — |
Medicare/Medicaid MMM
Efforts to advance interoperability and to ensure that technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services sector in a timely way, including efforts to advance Cures 2.0 (H.R. 6000), which would improve the process for updating the SCRIPT electronic prescribing standard to allow for more expeditious adoption of updated electronic prescribing standards.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KAREN SEALANDER | — |
| SCOTT AARON WEINSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.